SCHEMBL245584

SCHEMBL245584

C1=NCC2CCCCC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24190367 1.00
SCHEMBL1571046 0.95
SCHEMBL1571226 0.95
SCHEMBL2744247 0.95
Hydrochloric Acid SCHEMBL1570939 0.92
Hydrochloric Acid SCHEMBL30457850 0.92
SCHEMBL244154 0.77 ALDH1A1 (0.33)
SCHEMBL362734 0.77 ALDH1A1 (0.33)
SCHEMBL17776508 0.72
SCHEMBL11100092 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912576-A1 PROCESS FOR SYNTHESIZING CARBAPENEM ANTIBIOTICS Merck & Co., Inc. (US) 1999-05-06 EP claimed
WO-1998002439-A1 PROCESS FOR SYNTHESIZING CARBAPENEM ANTIBIOTICS MERCK & CO., INC. (US) 1998-01-22 WO claimed
EP-0462884-B1 TRH DERIVATIVES, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR ET COMPAGNIE (FR) 1993-06-16 EP claimed
WO-2024109688-A1 PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF 成都百裕制药股份有限公司 2024-05-30 WO disclosed
EP-3484982-B1 POLYESTER DISPERSANTS, SYNTHESIS AND USE THEREOF CHEVRON ORONITE CO (US) 2024-05-22 EP disclosed
CN-117916215-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2024-04-19 CN disclosed
US-11787788-B2 Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof CAPELLA THERAPEUTICS, INC. (US) 2023-10-17 US disclosed
US-20230271938-A1 BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES CAPELLA THERAPEUTICS, INC. 2023-08-31 US disclosed
US-11713322-B2 Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer CAPELLA THERAPEUTICS, INC. (US) 2023-08-01 US disclosed
US-20230234909-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS NUCMITO PHARMACEUTICALS CO. LTD. (CN) 2023-07-27 US disclosed
CN-116472034-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2023-07-21 CN disclosed
EP-1753428-A2 KINASE INHIBITORS AS THERAPEUTIC AGENTS Abbott Laboratories (US) 2007-02-21 EP disclosed
WO-2005110410-A2 KINASE INHIBITORS AS THERAPEUTIC AGENTS ABBOTT LABORATORIES (US) 2005-11-24 WO disclosed
EP-0899259-B1 Process for the preparation of cis-hexahydroisoindolines YUKI GOSEI YAKUHIN KOGYO KK (JP) 2004-10-13 EP disclosed
EP-1315761-A1 CROSSLINKABLE POLYMERIC COMPOSITIONS AND USE THEREOF 3M Innovative Properties Company (US) 2003-06-04 EP disclosed
WO-2002020625-A1 CROSSLINKABLE POLYMERIC COMPOSITIONS AND USE THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-03-14 WO disclosed
EP-0912576-A1 PROCESS FOR SYNTHESIZING CARBAPENEM ANTIBIOTICS Merck & Co., Inc. (US) 1999-05-06 EP disclosed
EP-0899259-A1 Process for the preparation of cis-hexahydroisoindolines YUKI GOSEI KOGYO CO., LTD. (JP) 1999-03-03 EP disclosed
WO-1998002439-A1 PROCESS FOR SYNTHESIZING CARBAPENEM ANTIBIOTICS MERCK & CO., INC. (US) 1998-01-22 WO disclosed
EP-0462884-B1 TRH DERIVATIVES, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR ET COMPAGNIE (FR) 1993-06-16 EP disclosed